AC Immune

$强生(JNJ)$ 已暂停其与$AC Immune(ACIU)$ 合作开发的阿尔茨海默病候选药物的 IIb 期 Retain 试验进一步入组。分析师猜测此次中断可能与招募困难有关。网页链接
这项为期四年的 Retain 研究于 2024 年启动，计划招募 500 名阿尔茨海默病前期（presym...

$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-26-002519  Act: 34  Size: 30 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004156  Size: 17 KB 网页链接

$AC Immune(ACIU)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-26-027342  Act: 34  Size: 34 MB 网页链接

$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-26-027345  Act: 34  Size: 3 MB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004151  Size: 20 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004153  Size: 14 KB 网页链接

$AC Immune(ACIU)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000470  Act: 33  Size: 5 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004453  Size: 25 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004150  Size: 18 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004163  Size: 21 KB 网页链接

$AC Immune(ACIU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-26-002195  Act: 34  Size: 11 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-004155  Size: 19 KB 网页链接

$AC Immune(ACIU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950103-26-005191  Size: 14 KB 网页链接